Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponenttranscription elongation factor complex

CCNT2 ERCC6

7.24e-0456152GO:0008023
GeneOntologyCellularComponentSWI/SNF superfamily-type complex

HMGXB4 ERCC6

2.11e-0396152GO:0070603
GeneOntologyCellularComponentATPase complex

HMGXB4 ERCC6

3.76e-03129152GO:1904949
HumanPhenoAbnormal number of teeth

KDM6A CREB3L1 ERCC6 REV3L CAMTA1

2.11e-0542165HP:0006483
HumanPhenoAbnormal lower lip morphology

KDM6A ERCC6 REV3L CAMTA1

6.91e-0524264HP:0000178
HumanPhenoSubdural hemorrhage

FGA ERCC6

1.05e-041462HP:0100309
PathwayKEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION

CCNT2 KDM6A

1.46e-0426102M47439
Pubmed

Functional proteomics mapping of a human signaling pathway.

ZNF484 L1TD1 KDM6A STIM2 ERCC6

3.63e-0659115515231748
Pubmed

Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China.

ERCC6 REV3L

6.52e-052815219661089
CoexpressionPRC2_EED_DN.V1_UP

LUZP4 REV3L SEMA6D

1.62e-04191153M2736
CoexpressionGSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN

CCNT2 REV3L SEMA6D

1.83e-04199153M6646
CoexpressionGSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP

CCNT2 ERCC6 SEMA6D

1.86e-04200153M6635
CoexpressionGSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP

SLC16A6 STIM2 HMGXB4

1.86e-04200153M6537
CoexpressionGSE6674_CPG_VS_PL2_3_STIM_BCELL_DN

SLC16A6 KDM6A HMGXB4

1.86e-04200153M6938
Drugrofecoxib; Up 200; 10uM; PC3; HG-U133A

LUZP4 PCNX1 CREB3L1 REV3L

7.31e-06200154463_UP
DrugProscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A

CCNT2 KDM6A PCNX1

1.46e-041601534404_UP
DrugDigoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A

CCNT2 KDM6A PCNX1

1.62e-041661535324_UP
DrugDigoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A

CCNT2 KDM6A PCNX1

1.74e-041701534680_UP
DrugEllipticine [519-23-3]; Down 200; 16.2uM; PC3; HT_HG-U133A

CCNT2 KDM6A HMGXB4

2.06e-041801535779_DN
DrugMitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; PC3; HT_HG-U133A

KDM6A PCNX1 HMGXB4

2.20e-041841536755_DN
DrugHomochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; PC3; HT_HG-U133A

CCNT2 KDM6A PCNX1

2.20e-041841537295_UP
DrugDiltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; PC3; HT_HG-U133A

CCNT2 KDM6A CREB3L1

2.45e-041911536710_DN
DrugPaclitaxel [33069-62-4]; Up 200; 4.6uM; PC3; HT_HG-U133A

KDM6A LUZP4 PCNX1

2.53e-041931536720_UP
DrugEstropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A

PCNX1 ERCC6 SEMA6D

2.57e-041941536068_DN
DrugTolnaftate [2398-96-1]; Down 200; 13uM; PC3; HT_HG-U133A

CCNT2 KDM6A PCNX1

2.57e-041941534221_DN
DrugBetahistine mesylate [54856-23-4]; Down 200; 17.2uM; HL60; HT_HG-U133A

CCNT2 PCNX1 ERCC6

2.57e-041941532472_DN
DrugAzathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A

KDM6A PCNX1 SEMA6D

2.61e-041951534106_DN
DrugNetilmicin sulfate [56931-57-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A

CCNT2 PCNX1 ERCC6

2.65e-041961533524_DN
Drug6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A

CCNT2 KDM6A PCNX1

2.65e-041961532511_DN
DrugNaloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HT_HG-U133A

CCNT2 PCNX1 CREB3L1

2.65e-041961534645_DN
DrugIntegrilin

FGA CREB3L1

2.66e-0437152CID000123610
Drug3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A

PCNX1 ERCC6 SEMA6D

2.69e-041971536060_DN
DrugSulfabenzamide [127-71-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A

LUZP4 ERCC6 SEMA6D

2.69e-041971534979_UP
DrugFoliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A

CCNT2 KDM6A PCNX1

2.69e-041971534761_DN
DrugPilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A

CCNT2 PCNX1 ERCC6

2.69e-041971533300_DN
DrugProcaine hydrochloride [51-05-8]; Down 200; 14.6uM; HL60; HT_HG-U133A

CCNT2 KDM6A PCNX1

2.73e-041981531838_DN
Drug0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A

CCNT2 KDM6A PCNX1

2.73e-041981537391_UP
DrugSR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A

KDM6A PCNX1 ERCC6

2.73e-041981534977_UP
DrugSulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A

L1TD1 PCNX1 CREB3L1

2.73e-041981533218_UP
Drugnovobiocin sodium, USP; Up 200; 100uM; MCF7; HG-U133A

CCNT2 LUZP4 SEMA6D

2.73e-04198153342_UP
DrugButirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A

PCNX1 ERCC6 SEMA6D

2.73e-041981536080_DN
DrugAcetazolamide [59-66-5]; Up 200; 18uM; PC3; HT_HG-U133A

CCNT2 KDM6A REV3L

2.77e-041991531808_UP
Drug(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A

CCNT2 PCNX1 HMGXB4

2.77e-041991535003_DN
Drugamitriptyline hydrochloride; Up 200; 1uM; MCF7; HG-U133A

LUZP4 CREB3L1 SEMA6D

2.77e-04199153167_UP
Drug1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A

CCNT2 LUZP4 PCNX1

2.77e-041991531_UP
DrugIsometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A

KDM6A PCNX1 SEMA6D

2.77e-041991535502_DN
Drug1,1-dimethylbiguanide hydrochloride; Up 200; 0.1uM; MCF7; HG-U133A

FGA CCNT2 LUZP4

2.81e-042001533_UP
DrugCID5311082

FGA CREB3L1

3.60e-0443152CID005311082
Drugoxolinic acid

CREB3L1 REV3L

3.95e-0445152CID000004628
Diseasesmoking behaviour measurement

REV3L CAMTA1 SEMA6D

1.79e-04222153EFO_0005671
Diseasestomach cancer (is_implicated_in)

KDM6A ERCC6

6.04e-0472152DOID:10534 (is_implicated_in)
Diseasealcohol use disorder measurement, alcohol consumption measurement

CREB3L1 SEMA6D

1.09e-0397152EFO_0007878, EFO_0009458
Diseaseopioid use disorder

CREB3L1 SEMA6D

1.18e-03101152EFO_0010702
Diseasecolorectal cancer (is_implicated_in)

KDM6A ERCC6

1.69e-03121152DOID:9256 (is_implicated_in)
Diseasemean arterial pressure

CCNT2 CREB3L1 STIM2

1.88e-03499153EFO_0006340
Diseaseunipolar depression, mood disorder

CREB3L1 CAMTA1

2.07e-03134152EFO_0003761, EFO_0004247
Diseasecannabis dependence

REV3L SEMA6D

2.10e-03135152EFO_0007191
Diseasegestational age

PCNX1 CAMTA1

2.19e-03138152EFO_0005112
Diseaselung non-small cell carcinoma (is_implicated_in)

KDM6A ERCC6

2.22e-03139152DOID:3908 (is_implicated_in)
Diseaserosacea severity measurement

CAMTA1 SEMA6D

2.48e-03147152EFO_0009180

Protein segments in the cluster

PeptideGeneStartEntry
KHSSPHISRDHKEKH

CCNT2

546

O60583
HISRDHKEKHKEHPS

CCNT2

551

O60583
HKEKHKEHPSSRHHT

CCNT2

556

O60583
KEHPSSRHHTSSHKH

CCNT2

561

O60583
GKHEHSHSKGSSREK

CAMTA1

311

Q9Y6Y1
HLQHDHLDSTHETTK

CREB3L1

466

Q96BA8
HKSKTKHHSVAEEET

ERCC6

1181

Q03468
ERSHGHSERSHGHSK

LUZP4

216

Q9P127
NEKRSHHKDHSDSES

KDM6A

1051

O15550
KHTHKERGTDSEHTH

PCNX1

646

Q96RV3
GSSSHSESKKEHHRK

HMGXB4

136

Q9UGU5
ADHEGTHSTKRGHAK

FGA

611

P02671
HHHSGETKVVSHRGK

SLC16A6

481

O15403
EVHKDKESSKGHTRH

REV3L

356

O60673
TNKHSHLHREDKHIT

STIM2

106

Q9P246
HKSHFITHERIHTGE

ZNF484

591

Q5JVG2
HSEKAHGHGASRKET

SEMA6D

791

Q8NFY4
SLEMSHDEHKKHSHT

L1TD1

561

Q5T7N2
HDEHKKHSHTNLSIS

L1TD1

566

Q5T7N2